Nextrove Invites You to the 2025 Global Pharmacovigilance Annual Summit in China

About Nextrove

Nextrove leads the industry in Pharmacovigilance Professional Services and Solutions. Our unwavering mission, “Empowering Clients to Improve Patient Safety,” propels us on the path to realizing our vision of becoming the first choice for Life Sciences professional services and solutions, in service of our clients, partners, and, above all, the patients we ultimately serve.


www.nextrove.com
info@nextrove.com
+1 347 551 1700

Nextrove LLC.
116 Village Boulevard,
Princeton Forrestal Village, Suite 208
Princeton, NJ 08540, USA

Nextrove China
2 / F, 2900 Nanxingang Road,
Fengxian District,
Shanghai
China

Shanghai, China — Nextrove is honored to invite you to the 2025 Global Pharmacovigilance Annual Summit, an exclusive in-person event .

Taking place this September in both Shanghai and Beijing, the summit will unite global regulators, industry leaders, and innovators under the theme: “From China to the World: Scaling Global Pharmacovigilance Through AI”

Event Dates & Times

  • Shanghai: Wednesday, September 10, 2025 | 13:00–17:00
  • Beijing: Friday, September 12, 2025 | 13:00–17:00

Summit Highlights:

  • Discover how AI seamlessly integrates multi-source safety data to generate actionable insights for regulators and sponsors worldwide.
  • Understand how China is emerging as a global leader in AI-driven safety innovation amidst rapidly evolving regulatory environments.
  • Explore Nextrove’s commitment to local excellence—adapting global solutions through Chinese talent, processes, and technologies.
  • Engage with thought leaders on the future of pharmacovigilance and the critical alignment of regulatory expertise, innovation, and international collaboration.

Whether you’re a global pharmaceutical sponsor, safety professional, or regulatory expert, this summit offers a vital platform to connect, learn, and shape the future of drug safety together.

Registration is now open

Join us as we lead the global transformation of pharmacovigilance—starting from China.

REGISTER NOW

Stay tuned — additional speaker details and session topics will be announced soon.

Privacy Preference Center